Indeed, it was already clear from studies in cell lines and animal models that substantial reduction of cancer cell viability in vitro and tumor shrinkage in vivo occur only in settings where stable and heritable genetic alterations of MET sustain oncogene ‘addiction’. The gene discussed is MET; the disease is neoplasm.